ZIVO · Zivo Bioscience, Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the financial statements are issued.”View the 10-Q filed Nov 14, 2025
Every disclosed holder of ZIVO in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns ZIVO
13F quarter Sep 30, 2026, combined view: filers that have not filed yet carry their Jun 30, 2026 positions| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 4,360 | 0.11% |
| Insiders (Forms 3, 4, 5) | 2,105,854 | 54.15% |
| 13D/G-only blocks | 91,484 | 2.35% |
| Remaining | 1,686,897 | 43.38% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 3,888,595, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of ZIVO
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
|
583,615 | ||
| 2 |
|
572,942 | ||
| 2.1 |
|
472,942 | ||
| 3 |
|
519,292 | ||
| 3.1 |
|
458,371 | ||
| 4 |
|
279,481 | ||
| 5 |
|
130,906 | ||
| 6 |
Mark E. Strome
13D
CIK 1713153 · Unknown · Jun 2, 2021
|
91,484 | ||
| 7 |
|
19,618 | ||
| 8 |
CoreCap Advisors, LLC
13F
CIK 1902501 · Registered investment adviser · Sep 30, 2026
|
4,360 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.